Articles from Antidepressants

Primary tabs

Antidepressant Eases Long COVID Fatigue, Study Shows - miragenews.com

Submitted by Anonymous (not verified) on Mon, 03/30/2026 - 21:04

Antidepressant Eases Long COVID Fatigue, Study Shows miragenews.com

Read more about Antidepressant Eases Long COVID Fatigue, Study Shows - miragenews.com
Log in to post comments

Common antidepressant prescribed to thousands may reduce debilitating fatigue linked to long COVID - Daily Mail

Submitted by Anonymous (not verified) on Mon, 03/30/2026 - 21:00

Common antidepressant prescribed to thousands may reduce debilitating

Common antidepressant can treat long COVID fatigue symptoms: study - CTV News

Submitted by Anonymous (not verified) on Mon, 03/30/2026 - 21:00

Common antidepressant can treat long COVID fatigue symptoms: study CTV News

Read more about Common antidepressant can treat long COVID fatigue symptoms: study - CTV News
Log in to post comments

Blocking NOX-1 enzyme may extend ketamine's antidepressant effects - Medical Xpress

Submitted by Anonymous (not verified) on Mon, 03/30/2026 - 19:00

Blocking NOX-1 enzyme may extend ketamine's antidepressant effects Medical Xpress

Read more about Blocking NOX-1 enzyme may extend ketamine's antidepressant effects - Medical Xpress
Log in to post comments

Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy for Patients with Inadequate Response to Antidepressants - biospace.com

Submitted by Anonymous (not verified) on Mon, 03/30/2026 - 17:03

Neurolief Secures Additional $6 Million Investment Following FDA Appro

Blocking NOX-1 Extends Ketamine’s Effectiveness for Depression - Neuroscience News

Submitted by Anonymous (not verified) on Mon, 03/30/2026 - 15:18

Blocking NOX-1 Extends Ketamine’s Effectiveness for Depression Neuroscience News

Read more about Blocking NOX-1 Extends Ketamine’s Effectiveness for Depression - Neuroscience News
Log in to post comments

Ayahuasca-derived DMT study shows positive effects on depression therapy in trials - Clinical Trials Arena

Submitted by Anonymous (not verified) on Mon, 03/30/2026 - 14:50

Ayahuasca-derived DMT study shows positive effects on depression therapy in trials Clinical Trials Arena

NOX-1 identified as key molecular target to prolong ketamine's antidepressant effects - News-Medical

Submitted by Anonymous (not verified) on Mon, 03/30/2026 - 13:12

NOX-1 identified as key molecular target to prolong ketamine's antidepressant effects News-Medical

Neurolief: $6 Million Investment Raised For FDA-Approved At-Home Depression Neuromodulation Therapy - Pulse 2.0

Submitted by Anonymous (not verified) on Mon, 03/30/2026 - 12:30

Neurolief: $6 Mil

Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy for Patients with Inadequate Response to Antidepressants - PR Newswire

Submitted by Anonymous (not verified) on Mon, 03/30/2026 - 11:30

Neurolief Secures Additional $6 Million Inve

Main menu

Articles from Antidepressants

Primary tabs

Antidepressant Eases Long COVID Fatigue, Study Shows - miragenews.com

Common antidepressant prescribed to thousands may reduce debilitating fatigue linked to long COVID - Daily Mail

Common antidepressant can treat long COVID fatigue symptoms: study - CTV News

Blocking NOX-1 enzyme may extend ketamine's antidepressant effects - Medical Xpress

Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy for Patients with Inadequate Response to Antidepressants - biospace.com

Blocking NOX-1 Extends Ketamine’s Effectiveness for Depression - Neuroscience News

Ayahuasca-derived DMT study shows positive effects on depression therapy in trials - Clinical Trials Arena

NOX-1 identified as key molecular target to prolong ketamine's antidepressant effects - News-Medical

Neurolief: $6 Million Investment Raised For FDA-Approved At-Home Depression Neuromodulation Therapy - Pulse 2.0

Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy for Patients with Inadequate Response to Antidepressants - PR Newswire

Pages

Main menu

You are here

User login

Articles from Antidepressants

Primary tabs

Pages